I once actually committed an act of journalism. I interviewed Hall of Fame relief pitcher Rich Gossage. It took place in January 2010 and it was a fantastic experience. Gossage was polite, accommodating, expansive and interesting. Most of all, his answers seemed very thoughtful. He wasn’t spouting off talking points or cliches. He was thinking about his answers and explaining himself.
The topic: mostly PED users and the Hall of Fame. Like most former players, Gossage was unhappy with the scourge of steroids. But he also struck a very realistic tone at the time, noting how complicated the matter was. His money quote, given in response to what he and other Hall of Famers might do if/when it is discovered that a current member of the Hall of Fame used PEDs, was this:
“I don’t really know what I’d do. We’d have to find out all the facts. It’s a big dark cloud. I don’t know what the scenario would look like“
He added that how the Hall of Fame voters treated guys like Barry Bonds and Roger Clemens, saying “if they let in some of those guys, I guess things are different. What I said about integrity yesterday still stands, but as for the Hall, we’d have to see how the writers handled it. I can only speak for what I believe.” He concluded by saying that he had no problem with cocaine users such as Dave Parker or Tim Raines being inducted.”
In the past four years Gossage’s tone on the matter has shifted from one of personal disapproval — here’s what I believe, but it’s not all up to me, as it were — to one far greater certainty and stridence. He spoke to the New York Post over the weekend, slamming PED users and arguing that all of the pre-PED home run records should be restored. He said “are you f***ing kidding me?” regarding PED guys and then offered a lot of nonsense about Ken Griffey Jr. and great home run hitters’ aging patterns (note: Hank Aaron, like Bonds, had some of his best seasons late in his career).
I don’t know what has changed with Gossage over the past four years to change him from a guy who, while believing what he believed about PEDs, did not believe he had a monopoly on wisdom on the matter to a guy who is so damn certain and, if you put him in charge, would purge records from the books. But given my previous interaction with him, it’s somewhat disappointing.
Yahoo Sports’ Jeff Passan reports that third baseman Jose Ramirez is finalizing a four-year extension with the Indians. The deal is said to be worth north of $30 million, and may crest $50 million if all options are exercised. While the extension won’t take effect until the 2018 season, it guarantees Ramirez a $26 million sum with two options worth $11 and $13 million and will give the Indians control of the infielder through the 2023 season.
Ramirez, 24, is entering his fifth season in the Indians’ organization. He posted career-high numbers during his first full season in the majors, slashing .312/.363/.461 with 11 home runs, 22 stolen bases and 4.8 fWAR in 2016. He’s projected to have a strong follow-up season at the plate and will likely see some time at second base as Jason Kipnis works his way back from a shoulder injury.
Although 2016 only showcased the beginning of Ramirez’s success with the club, FanRag Sports’ Jon Heyman says it’s a standard move for Cleveland to “sign their stars early,” and indicates that Ramirez was rumored to want the deal. Jeff Todd of MLB Trade Rumors adds that the extension will keep Ramirez under club control through three arbitration-eligible years and one year of potential free agency.
Diamondbacks’ right-hander Tyler Jones is headed back to the Yankees, the teams announced on Friday. The Diamondbacks had previously selected Jones in the Rule 5 draft last December, but elected to leave the 27-year-old off of their 40-man roster heading into the 2017 season. Rule 5 draft rules stipulate that when a player is not kept on the receiving team’s roster, the player must be offered back to his original team.
Jones signed a minor league contract with the Yankees prior to the 2016 season. He pitched to an impressive 2.17 ERA, 2.2 BB/9 and 13.2 SO/9 over 45 2/3 innings with Double-A Trenton, but was unable to make the leap to Triple-A or beyond during his stay with the organization.
Jones’ outlook with the Diamondbacks appeared slightly more promising. GM Mike Hazen described the righty as a power arm with a “good fastball and power curveball” after selecting him in the Rule 5 draft, and early reports indicated that Jones would be in the mix for a bullpen spot. A rough spring performance — underscored by his lack of experience at the Triple-A and major league levels — undid most of that confidence, however, and the Diamondbacks weren’t willing to keep him on the active roster throughout the entire 2017 season in order to acquire his control rights.
Jones is set to open the season with Triple-A Scranton/Wilkes-Barre, per a report from the Yankees.